The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

ABDX Insider Trading

Insider Ownership Percentage: 54.25%
Insider Buying (Last 12 Months): £322,250
Insider Selling (Last 12 Months): GBX 0

Abingdon Health Insider Trading History Chart

This chart shows the insider buying and selling history at Abingdon Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Abingdon Health Share Price & Price History

Current Price: GBX 9.50
Price Change: Price Decrease of -0.5 (-5.00%)
As of 06/2/2023 01:00 AM ET

This chart shows the closing price history over time for ABDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

Abingdon Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/23/2022Chris Henry Francis YatesInsiderBuy125,000GBX 7£8,750
9/15/2022Chris Henry Francis YatesInsiderBuy50,000GBX 627£313,500
4/6/2021Melanie RossInsiderBuy5,338GBX 93£4,964.34
See Full Table
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

SEC Filings (Institutional Ownership Changes) for Abingdon Health (LON:ABDX)

15.59% of Abingdon Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Abingdon Health logo
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2. It also provides AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Read More on Abingdon Health

Today's Range

Now: GBX 9.50
Low: 9.50
High: 10.44

50 Day Range

MA: GBX 8.25
Low: 5.34
High: 13

52 Week Range

Now: GBX 9.50
Low: 3.60
High: 15.39

Volume

127,509 shs

Average Volume

427,200 shs

Market Capitalization

£11.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.33

Who are the company insiders with the largest holdings of Abingdon Health?

Abingdon Health's top insider investors include:
  1. Chris Henry Francis Yates (Insider)
Learn More about top insider investors at Abingdon Health.